GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SOC Telemed Inc (NAS:TLMDW) » Definitions » Asset Turnover

SOC Telemed (SOC Telemed) Asset Turnover : 0.53 (As of Dec. 2021)


View and export this data going back to 2020. Start your Free Trial

What is SOC Telemed Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. SOC Telemed's Revenue for the six months ended in Dec. 2021 was $94.44 Mil. SOC Telemed's Total Assets for the quarter that ended in Dec. 2021 was $179.58 Mil. Therefore, SOC Telemed's Asset Turnover for the quarter that ended in Dec. 2021 was 0.53.

Asset Turnover is linked to ROE % through Du Pont Formula. SOC Telemed's annualized ROE % for the quarter that ended in Dec. 2021 was -90.99%. It is also linked to ROA % through Du Pont Formula. SOC Telemed's annualized ROA % for the quarter that ended in Dec. 2021 was -56.29%.


SOC Telemed Asset Turnover Historical Data

The historical data trend for SOC Telemed's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOC Telemed Asset Turnover Chart

SOC Telemed Annual Data
Trend Dec19 Dec20 Dec21
Asset Turnover
1.32 0.86 0.53

SOC Telemed Semi-Annual Data
Dec19 Dec20 Dec21
Asset Turnover 1.32 0.86 0.53

Competitive Comparison of SOC Telemed's Asset Turnover

For the Medical Care Facilities subindustry, SOC Telemed's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SOC Telemed's Asset Turnover Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SOC Telemed's Asset Turnover distribution charts can be found below:

* The bar in red indicates where SOC Telemed's Asset Turnover falls into.



SOC Telemed Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

SOC Telemed's Asset Turnover for the fiscal year that ended in Dec. 2021 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2021 )/( (Total Assets (A: Dec. 2020 )+Total Assets (A: Dec. 2021 ))/ count )
=94.442/( (84.939+274.225)/ 2 )
=94.442/179.582
=0.53

SOC Telemed's Asset Turnover for the quarter that ended in Dec. 2021 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2021 )/( (Total Assets (Q: Dec. 2020 )+Total Assets (Q: Dec. 2021 ))/ count )
=94.442/( (84.939+274.225)/ 2 )
=94.442/179.582
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


SOC Telemed  (NAS:TLMDW) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

SOC Telemed's annulized ROE % for the quarter that ended in Dec. 2021 is

ROE %**(Q: Dec. 2021 )
=Net Income/Total Stockholders Equity
=-101.084/111.0955
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-101.084 / 188.884)*(188.884 / 179.582)*(179.582/ 111.0955)
=Net Margin %*Asset Turnover*Equity Multiplier
=-53.52 %*1.0518*1.6165
=ROA %*Equity Multiplier
=-56.29 %*1.6165
=-90.99 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2021) net income data. The Revenue data used here is two times the semi-annual (Dec. 2021) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

SOC Telemed's annulized ROA % for the quarter that ended in Dec. 2021 is

ROA %(Q: Dec. 2021 )
=Net Income/Total Assets
=-101.084/179.582
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-101.084 / 188.884)*(188.884 / 179.582)
=Net Margin %*Asset Turnover
=-53.52 %*1.0518
=-56.29 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2021) net income data. The Revenue data used here is two times the semi-annual (Dec. 2021) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


SOC Telemed Asset Turnover Related Terms

Thank you for viewing the detailed overview of SOC Telemed's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


SOC Telemed (SOC Telemed) Business Description

Traded in Other Exchanges
N/A
Address
1768 Business Center Drive, Suite 100, Reston, VA, USA, 20190
SOC Telemed Inc is a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare systems based on number of clients. It provides technology enabled clinical solutions which include acute teleNeurology, telePsychiatry, and teleICU, and telePulmonology service. It supports specialty care, providing time-sensitive specialty care when patients are vulnerable and may not otherwise have access. Its solution was developed to support complex workflows in the acute care setting by integrating cloud-based software platform, Telemed IQ, with a panel of patient advocates and a network of clinical specialists to create a seamless, acute telemedicine solution.
Executives
David R. Fletcher officer: Interim CFO C/O SOC TELEMED, INC., 1768 BUSINESS CENTER DRIVE, SUITE 100, RESTON VA 20190
David Mikula officer: Chief Operating Officer C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Gyasi C. Chisley director C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Christopher M. Gallagher director C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Steven J Shulman director 1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Christopher K Knibb officer: Chief Financial Officer C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Warburg Pincus Partners Ii, L.p. director, 10 percent owner 450 LEXINGTON AVENUE, C/O WARBURG PINCUS LLC, NEW YORK NY 10017
Anne Mcgeorge director C/O MAGENTA THERAPEUTICS, INC., 100 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE MA 02139
Wpxi Finance, Lp director, 10 percent owner C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Wpxi Gp, L.p. director, 10 percent owner C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Warburg Pincus & Co. director, 10 percent owner 450 LEXINGTON AVENUE, NEW YORK, NY NY 100173147
Amr Kronfol director C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Joseph P Greskoviak director C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Sean Banerjee officer: Chief Technology Officer C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
John W. Kalix director, officer: Chief Executive Officer C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190